Janssen Res And Dev Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JANSSEN RES AND DEV, and what generic and branded alternatives to JANSSEN RES AND DEV drugs are available?
JANSSEN RES AND DEV has one approved drug.
Drugs and US Patents for Janssen Res And Dev
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Janssen Res And Dev
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-001 | Approved Prior to Jan 1, 1982 | 3,454,643 | ⤷ Sign Up |
Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-002 | Approved Prior to Jan 1, 1982 | 3,882,246 | ⤷ Sign Up |
Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-002 | Approved Prior to Jan 1, 1982 | 3,454,643 | ⤷ Sign Up |
Janssen Res And Dev | FLEXERIL | cyclobenzaprine hydrochloride | TABLET;ORAL | 017821-001 | Approved Prior to Jan 1, 1982 | 3,882,246 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.